Equities

Shilpa Medicare Ltd

SHILPAMED:NSI

Shilpa Medicare Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)533.05
  • Today's Change-13.85 / -2.53%
  • Shares traded189.30k
  • 1 Year change+124.58%
  • Beta0.9611
Data delayed at least 15 minutes, as of Jun 14 2024 11:20 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Shilpa Medicare Limited is an India-based pharmaceutical company. The Company is engaged in the manufacturing of active pharmaceutical ingredients (APIs), formulation and development service. It is engaged in APIs, intermediates, formulations, new drug delivery systems, peptides / biotech products and specialty chemicals, and others. The Company supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Pemetrexed, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various international markets including United States of America, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. Its non-Oncology API products include Ambroxol (Mucolytic agent), Tranexmic Acid and Ursodeoxycholic Acid. Its Injectable Dosage Forms include Myelodysplastic Syndrome, Breast Cancer, Multiple Myeloma, and more. Its Oral Solid Dosage Forms include Psoriasis, Prostate Cancer, Multiple Sclerosis, and others.

  • Revenue in INR (TTM)11.51bn
  • Net income in INR318.74m
  • Incorporated1987
  • Employees1.03k
  • Location
    Shilpa Medicare LtdShilpa House#12-6-214/A1,, Hyderabad Road,RAICHUR 584135IndiaIND
  • Phone+91 8 532238704
  • Fax+91 8 532238876
  • Websitehttps://www.vbshilpa.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
SHILPAMED:NSI since
announced
Transaction
value
Pilnova Pharma IncAnnounced02 Nov 202302 Nov 2023Announced51.09%--
Data delayed at least 15 minutes, as of Jun 14 2024 11:20 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Morepen Laboratories Ltd16.90bn961.60m28.69bn1.65k29.853.3922.051.701.881.8833.1116.581.414.455.74--8.047.9011.5013.3437.1533.655.725.491.5933.730.0331--19.2517.08148.6327.2247.03--
Indoco Remedies Ltd18.17bn984.70m30.07bn6.10k31.002.7115.921.6510.5210.52193.15120.380.95571.654.80--5.106.887.029.8569.2366.665.346.930.98254.010.37712.678.9113.41-30.78--34.5437.97
SeQuent Scientific Ltd13.70bn-358.69m30.60bn478.00--4.6695.832.23-1.45-1.4556.2726.370.89252.194.05---1.931.09-3.271.7644.5342.74-2.161.180.76020.13760.4062---3.605.6870.40--6.96--
Supriya Lifescience Ltd5.70bn1.19bn32.06bn392.0026.923.9323.765.6214.8014.8070.87101.310.6552.215.81--13.6819.0815.1924.0461.1258.7120.8824.714.0666.400.00672.8823.7415.4732.5624.7583.79--
Gufic BioSciences Ltd8.07bn861.36m35.78bn1.63k40.786.7234.694.448.758.7581.9053.110.82582.033.01--8.8211.4613.3219.2151.6746.9910.6810.461.088.370.3847--16.8018.128.0731.4653.8314.87
Hikal Ltd17.85bn696.00m36.84bn2.14k52.883.1019.682.065.655.65144.7796.320.73252.663.60--2.865.074.037.5153.7947.223.905.860.87612.650.407716.88-11.792.34-11.20-7.559.720.00
Unichem Laboratories Ltd17.05bn-704.74m38.74bn3.12k--1.6490.592.27-10.02-10.02238.88335.540.53590.99952.84---2.22-1.67-2.81-2.0361.0257.79-4.13-3.991.40-0.57330.0948--26.947.6465.15---35.00--
Advanced Enzyme Technologies Ltd6.24bn1.33bn44.16bn338.0033.113.3425.657.0811.9311.9355.83118.410.42191.066.27--9.2610.8210.2311.9376.8372.8121.9524.596.2257.810.033415.1715.398.2626.193.7227.8553.42
Aarti Drugs Ltd25.29bn1.71bn47.92bn1.50k28.013.7421.481.9018.6118.61274.44139.401.043.353.22--7.079.7310.9815.7433.6524.966.798.251.057.910.3056---6.9010.133.0713.8224.96--
Shilpa Medicare Ltd11.51bn318.74m52.13bn1.03k144.852.5637.284.533.683.68134.51208.370.38411.233.21--1.072.841.413.6564.6361.372.787.030.76711.410.3424--9.669.44198.15-22.26-9.26--
Orchid Pharma Ltd8.19bn915.95m53.65bn838.0055.274.5942.006.5519.1419.14169.90230.580.58971.973.99--6.80-0.97348.80-1.4040.8743.3211.53-2.402.034.680.1031--23.056.4373.595.8457.79--
Aarti Pharmalabs Ltd18.53bn2.17bn54.93bn1.40k25.323.1318.932.9723.9423.94204.45193.890.76981.643.86--9.01--12.30--44.90--11.71--1.0118.170.1397---4.76--12.10------
Blue Jet Healthcare Ltd7.12bn1.64bn67.99bn--41.508.0435.449.559.449.4441.0448.730.74092.463.42--17.05--21.25--55.82--23.01--2.801,257.130.00---1.30--2.33------
Marksans Pharma Ltd21.77bn3.14bn72.88bn1.40k23.213.5318.733.356.936.9348.1145.570.8941.885.01--12.9314.6215.3618.5252.3251.2214.4614.033.1934.300.10486.6617.5616.8417.8032.6273.8664.38
F D C Ltd19.43bn3.05bn75.10bn6.37k24.793.5821.773.8718.6118.61118.69128.810.80771.8316.19--12.6812.0514.5613.7366.2362.8115.7015.852.1874.020.0097--8.9212.2457.3012.4516.93--
Data as of Jun 14 2024. Currency figures normalised to Shilpa Medicare Ltd's reporting currency: Indian Rupee INR

Institutional shareholders

6.92%Per cent of shares held by top holders
HolderShares% Held
ICICI Prudential Asset Management Co. Ltd.as of 30 Apr 20243.22m3.30%
Bandhan Asset Management Co. Ltd.as of 30 Apr 20241.25m1.28%
SBI Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Apr 20241.10m1.13%
Dimensional Fund Advisors LPas of 09 May 2024422.47k0.43%
WhiteOak Capital Asset Management Ltd.as of 30 Apr 2024409.84k0.42%
SSgA Funds Management, Inc.as of 09 May 2024191.60k0.20%
Motilal Oswal Asset Management Co. Ltd.as of 30 Apr 202472.53k0.07%
Dimensional Fund Advisors Ltd.as of 30 Apr 202439.94k0.04%
American Century Investment Management, Inc.as of 09 May 202427.55k0.03%
ITI Asset Management Ltd. (India)as of 31 May 202427.11k0.03%
More ▼
Data from 31 Mar 2024 - 06 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.